Bio-Thera Solutions announces positive top-line results for BAT1706, a proposed biosimilar to Avastin

This article was originally published here

BAT1706 is being developed by Bio-Thera Solutions as a proposed biosimilar to Avastin. The trial demonstrated equivalence in overall response rate (ORR) for the first-line treatment of patients

The post Bio-Thera Solutions announces positive top-line results for BAT1706, a proposed biosimilar to Avastin appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply